Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genome-wide Screen to Identify Regulators of Heterochromatin Recruitment or Maintenance
Assay data:403 Active, 24006 Tested
SummaryPubMed Citation
CRACM1 Is a Plasma Membrane Protein Essential for Store-Operated Ca2+ Entry
Assay data:2069 Active, 19730 Tested
MAPK Signaling Pathway Screen
Assay data:1643 Active, 22533 Tested
Genes involved in store-operated calcium entry
Assay data:75 Active, 22913 Tested
Genes involved in protein secretion and Golgi organization
Assay data:1068 Active, 22533 Tested
Hh Signalling
Assay data:503 Active, 21305 Tested
Functional genomic analysis of the Wnt-Wingless Signaling Pathway
Assay data:233 Active, 21998 Tested
Factors affecting human androgen receptor transcriptional activation
Assay data:246 Active, 23856 Tested
Virus Titer Reduction Secondary Screen for Compounds that Inhibit VEEV (TC-83 strain) (5)
Assay data:14 Active, 16 Tested
SummaryCompounds, ActiveRelated BioAssays by DepositorRelated BioAssays by Same Project
A genome-wide RNA interference screen identifies putative chromatin regulators essential for E2F repression
Assay data:18 Active, 21306 Tested
Identification of novel genes involved in light-dependent CRY degradation
Assay data:170 Active, 21305 Tested
Screen for novel regulators of G2/M checkpoint
Assay data:62 Active, 22574 Tested
Presto-Tango -Arrestin Recruitment Assay from US Patent US11472787: "Docosahexaenoic acid endocannabinoid epoxide derivative compositions"
Assay data:5 Active, 5 Activity ≤ 1 nM, 5 Activity ≤ 1 µM, 5 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Time-Resolved Fret (TR-FRET) Assay from US Patent US9187459: "Quinazoline-7-ether compounds and methods of use"
Radioligand Binding Assay from Article 10.1124/jpet.105.097006: "Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist."
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro Enzyme Assay from US Patent US8487096: "Imidazo[1,2-B][1,2,4]triazines as C-MET inhibitors"
Inhibition of Coagulation Factor XIa from US Patent US11541049: "Tetrahydroisoquinoline derivatives, preparation process and use thereof"
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro c-Met Kinase Enzyme Assays from US Patent US10919901: "Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors"
Kinase Enzyme Assays from US Patent US10472367: "Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors"
Cell Based Assay from US Patent US9422273: "Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response"
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on